atenolol has been researched along with arginine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; Widdop, RE | 1 |
| DuCailar, G; Mimran, A; Ribstein, J | 1 |
| Bowman, AJ; Chen, CP; Ford, GA | 1 |
| Cabral, AM; Cunha, RS; Vasquez, EC | 1 |
| Carroll, M; Hinson, JP; Kapas, S; Renshaw, D; Thomson, LM | 1 |
| Arcucci, O; Cipolletta, E; De Luca, N; Di Renzo, G; Iaccarino, G; Izzo, R; Lanni, F; Trimarco, V | 1 |
| Boccioletti, V; Cominacini, L; Garbin, U; Manfro, S; Pasini, AF; Stranieri, C | 1 |
| Barlag, RE; Funovic, P; Jacob, RF; Korda, M; Kubant, R; Malinski, T; Mason, RP | 1 |
| Boccioletti, V; Cominacini, L; Cominacini, M; Garbin, U; Manfro, S; Mozzini, C; Pasini, A; Pasini, AF; Stranieri, C | 1 |
| Li, Z; Liu, Y; Pang, X; Wang, Y; Wei, Z; Yin, S; Zhang, F | 1 |
| Niu, M; Shi, R; Wang, Y; Yin, S; Zhang, F | 1 |
1 review(s) available for atenolol and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for atenolol and arginine
| Article | Year |
|---|---|
Nitric oxide mediated venodilator effects of nebivolol.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ethanolamines; Hand; Humans; Infusions, Intravenous; Male; Nebivolol; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Vasodilation; Vasodilator Agents; Veins | 1994 |
Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitric Oxide Synthase Type III; Vasodilation | 2008 |
13 other study(ies) available for atenolol and arginine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.
Topics: Animals; Aorta, Thoracic; Arginine; Atenolol; Atropine; Cardiac Output; Heart; Heart Rate; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Rats; Reflex | 1992 |
Contrasting effect of antihypertensive treatment on the renal response to L-arginine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Atenolol; Calcium Channel Blockers; Cyclic GMP; Data Interpretation, Statistical; Female; Humans; Hypertension; Infusions, Parenteral; Kidney; Male; Middle Aged; Nitric Oxide; Renal Circulation; Time Factors | 1995 |
Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats.
Topics: Animals; Arginine; Atenolol; Atropine; Autonomic Nervous System; Blood Pressure; Ganglionic Blockers; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Trimethaphan; Vagus Nerve | 1993 |
Actions of neuropeptide Y on the rat adrenal cortex.
Topics: Adrenal Cortex; Adrenergic beta-Antagonists; Aldosterone; Animals; Arginine; Atenolol; Catecholamines; Neuropeptide Y; Pancreatic Polypeptide; Rats; Receptors, Neuropeptide Y; RNA, Messenger; Steroids | 2000 |
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Alleles; Antihypertensive Agents; Arginine; Atenolol; Blood Glucose; Cholesterol; Female; Follow-Up Studies; Glutamic Acid; Homozygote; Humans; Hyperlipidemias; Hypertension; Male; Metoprolol; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Risk Factors; Triglycerides | 2005 |
Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
Topics: Adrenergic beta-Antagonists; Amidohydrolases; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Cell Line; Endothelial Cells; Ethanolamines; Female; Humans; Male; Nebivolol; Nitric Oxide Synthase Type III; RNA, Messenger | 2007 |
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approach.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Aorta, Thoracic; Arginine; Atenolol; Cellular Senescence; Endothelium, Vascular; In Vitro Techniques; Metoprolol; Nanotechnology; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pterins; Rats; Rats, Inbred WKY; Superoxide Dismutase | 2008 |
Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta; Arginine; Atenolol; Blood Pressure; Enzyme Inhibitors; Hypertension; Male; NADPH Oxidases; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Up-Regulation; Vascular Remodeling | 2017 |
Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
Topics: Amidohydrolases; Angiotensin II; Animals; Arginine; Atenolol; Blood Pressure; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Protective Agents; Protein-Arginine N-Methyltransferases; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |